Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors. Filippova N, Yang X, Ananthan S, Calano J, et al. Cancer Res 2021;81:2220-2233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Filippova N, Yang X, Ananthan S, Calano J, et al. Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors. Cancer Res 2021;81:2220-2233.
PMID: 33602784